4//SEC Filing
Guiheen Lawrence P. 4
Accession 0001140361-24-040872
CIK 0001368514other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 9:00 PM ET
Size
18.9 KB
Accession
0001140361-24-040872
Insider Transaction Report
Form 4
Guiheen Lawrence P.
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-09$10.80/sh+9,000$97,200→ 162,941 total - Exercise/Conversion
Common Stock
2024-09-09$10.80/sh−9,000$97,200→ 0 totalExercise: $10.80Exp: 2025-01-30→ Common Stock (9,000 underlying) - Sale
Common Stock
2024-09-09$18.47/sh−9,000$166,189→ 153,941 total
Holdings
- 1,000(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $18.465 to $18.47. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Includes, as of the transaction date, (i) 12,020 restricted stock units granted on February 26, 2024, which will vest fully on February 26, 2025, subject to the Reporting Person's continued service as of such vesting date; and (ii) 141,921 shares of common stock owned by the Reporting Person.
- [F3]These shares are owned by the Guiheen Trust, of which the Reporting Person serves as a joint trustee.
- [F4]These options were granted on January 30, 2015 and vested in twenty-four equal monthly installments, becoming fully vested on January 30, 2017.
- [F5]The Reporting Person is exercising these options due, in part, to their near-term expiration date.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
Related Parties
1- filerCIK 0001554353
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 9:00 PM ET
- Size
- 18.9 KB